{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074233","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.651530+00:00","generated_at":"2026-06-01T04:09:50.270522+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"MiNK Therapeutics stockholders elect directors, ratify KPMG at 2024 annual meeting","bullets":["Annual meeting held June 12, 2024; 28,359,271 shares (81.71%) present or represented.","Brian Corvese and Peter Behner elected as Class III directors for three-year terms.","Ratification of KPMG LLP as independent auditor for FY2024 approved with 28,242,636 votes for.","Broker non-votes of 3,364,923 on director elections and none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074233","json":"https://secwatch.observer/filing/0000950170-24-074233.json","markdown":"https://secwatch.observer/filing/0000950170-24-074233.md","text":"https://secwatch.observer/filing/0000950170-24-074233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/0000950170-24-074233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024074233/inkt-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:09:50.270522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}